Seminars in Oncology
Volume 33, Supplement 10 , Pages S19-S25, October 2006

Bevacizumab in Older Patients and Patients With Poorer Performance Status

  • Paulo M. Hoff

      Affiliations

    • Dr Hoff has served as a member of a Roche advisory board.
    • Corresponding Author InformationAddress reprint requests to Paulo M. Hoff, MD, FACP, Centro de Oncologia, Hospital Sírio-Libanês, Rua Dona Adma Jafet, 91, São Paulo, SP Brazil 01308-050.

Centro de Oncologia, Hospital Sírio-Libanês, São Paulo, Brazil.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(06)00317-4

doi:10.1053/j.seminoncol.2006.08.006

Seminars in Oncology
Volume 33, Supplement 10 , Pages S19-S25, October 2006

Article Tools

* Image Usage & Resolution